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bjectives We aimed to explore the relationship of neointimal thickness (NT) to shear stress (SS)
fter implantation of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) compared with
are-metal stents (BMS). We then tested the hypothesis that drug elution attenuates the SS effect.
ackground Neointimal thickness after BMS implantation has been associated with SS; pertinent
ata for drug-eluting stents (DES) are limited.
ethods Three-dimensional coronary artery and stent reconstruction was performed in 30 patients
t 6-month follow-up after SES (n  10), PES (n  10), or BMS (n  10) implantation. Baseline SS at
he stent surface was calculated using computational ﬂuid dynamics and NT at follow-up was com-
uted in 3-dimensional space.
esults Neointimal thickness was lower in DES versus BMS (0.03  0.07 mm vs. 0.16  0.08 mm,
 0.001) and maximum NT was reduced in SES versus PES (0.33  0.13 mm vs. 0.46  0.13 mm,
 0.025). In the total population, both SS (slope: 0.05 mm/Pa, p  0.001) and DES (coefﬁcient
or DES vs. BMS: 0.17 mm, p  0.003) were independent predictors of NT. Subgroup analysis dem-
nstrated a signiﬁcant negative relationship of NT to SS in PES (slope: 0.05 mm/Pa, p  0.016)
nd BMS (slope: 0.05 mm/Pa, p  0.001). Sirolimus elution signiﬁcantly attenuated the effect of SS
n NT (interaction coefﬁcient for SES vs. BMS: 0.04 mm/Pa, p  0.023), whereas the SS effect re-
ained unchanged in PES (interaction coefﬁcient for PES vs. BMS: 0.01 mm/Pa, p  0.71).
onclusions Neointimal thickness is signiﬁcantly correlated (inversely) to SS in PES as in BMS. Siroli-
us elution abrogates the SS effect on the neointimal response following stent implantation,
hereas the SS effect is unchanged in PES. (J Am Coll Cardiol Intv 2010;3:1181–9) © 2010 by the
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1182oronary artery stenting successfully reduces atherosclerotic
tenoses providing a patent artery with preserved blood flow
ollowing intervention. In-stent restenosis due to neointimal
rowth constitutes a rather frequent sequela (incidence: 20%
o 40%) after implantation of a bare-metal stent (BMS) and
ften necessitates repeat revascularization (1). Among stan-
ard clinical and procedural characteristics influencing re-
tenosis occurrence, local hemodynamic factors, known to
lay a role in atherosclerosis (2), have also been implicated
n the pathobiology of neointimal hyperplasia. Blood flow–
erived shear stress (SS) on the in-stent endothelial surface
as been demonstrated to influence neointimal thickness
NT), which is increased in stent regions with low SS (3).
See page 1199
Drug-eluting stents (DES) have currently dominated offering
ery low restenosis rates owing to their potent antiprolifera-
tive effect (4). The first-generation
DES (i.e., sirolimus-eluting stents
[SES] and paclitaxel-eluting stents
[PES]) have been proven to reduce
neointimal growth of smooth mus-
cle cells (SMC) and endothelial
cells leading to decreased neointi-
mal hyperplasia or even tissue re-
gression (5–7). The possible role of
SS in predicting NT after DES
implantation has been investigated
by only 2 studies in small patient
series with SES (8,9), and they
reported contradictory results: 1
found an overall significant nega-
tive correlation of NT to SS in 6
patients, and the other reported no
association between neointimal
yperplasia volume and average SS in 11 diabetics with SES. No
uch data are available for a patient group with PES.
In this report, we assess NT at follow-up after SES and
ES implantation, and investigate its relationship with
aseline in-stent SS in comparison with a BMS patient
roup to test the hypothesis that drug elution attenuates the
ocal effect of SS. We used in vivo 3-dimensional coronary
rtery reconstruction and blood flow simulation for NT and
S computation.
ethods
atient population. Thirty patients, who underwent im-
lantation of SES (Cypher, Cordis/Johnson & Johnson,
ridgewater, New Jersey) (n  10), PES (Taxus, Boston
cientific, Natick, Massachusetts) (n  10), or BMS (n 
0), were studied by angiography and intravascular ultra-
bbreviations
nd Acronyms
D  3-dimensional
MS  bare-metal stent(s)
ES  drug-eluting stent(s)
VUS  intravascular
ltrasound
T  neointimal thickness
ES  paclitaxel-eluting
tent(s)
ES  sirolimus-eluting
tent(s)
MC  smooth muscle
ell(s)
S  shear stressound (IVUS) at 6-month follow-up when referred for bardiac catheterization at the University Hospital of Ioan-
ina because of positive routine follow-up noninvasive stress
esting. All patients had an otherwise uneventful follow-up
eriod. Patients were eligible if they had undergone angio-
raphically successful stent implantation (stent length 12
m; located at least 5 mm away from major bifurcations)
or de novo lesions in native coronary arteries and consented
o follow-up catheterization using IVUS. The exclusion
riteria were primary stenting in acute myocardial infarction
12 h after symptom onset), chronic total occlusion
esions, ejection fraction 50%, and serum creatinine 1.5
g/dl. None of the studied patients had angiographically
vident in-stent restenosis (50% in-stent diameter steno-
is) at follow-up.
All patients had received post-intervention dual anti-
latelet therapy: aspirin 100 mg/day indefinitely and clopi-
ogrel 75 mg/day for 1 month after BMS implantation and
or 12 months after DES implantation. The study was
pproved by the local institutional ethical committee, and
ach patient provided informed consent.
D reconstruction of coronary arteries and blood ﬂow
imulation. Three-dimensional (3D) reconstruction of the
oronary arteries was performed using a validated method
ased on the fusion of biplane angiographic and IVUS data
details in the Online Appendix) (10,11). Briefly, the end-
iastolic biplane angiographic images were used to reconstruct
he catheter path in 3D space, whereas the lumen and stent
determined by the leading edge of the stent struts) borders
ere detected in the digitized end-diastolic IVUS images
Online Fig. 1S). The detected borders were placed onto the
D catheter path to reconstruct the lumen at follow-up and the
tent surface (Figs. 1A to 1C); the 3D stent reconstruction
epresented the approximate lumen at baseline just after
tent implantation (12).
Blood flow simulation was performed using computa-
ional fluid dynamics techniques for generating the finite
olume (hexahedral) mesh of the 3D reconstruction (details
n Papafaklis et al. [13]) and solving the 3D Navier-Stokes
quations (ICEM CFD 5 and CFX 10, ANSYS, Inc.,
anonsburg, Pennsylvania). We modeled blood as a homo-
eneous and Newtonian fluid with a dynamic viscosity of
.0035 Pa  s and a density of 1,050 kg/m3, while the
rterial wall was considered rigid. Laminar flow was as-
umed and a patient-specific steady flow with a fully
eveloped profile was specified at the inlet. Coronary blood
ow for each patient was calculated by the number of the
ost-procedural angiogram frames required for the opacified
aterial to pass from the inlet to the outlet of the arterial
ection being studied, the corresponding 3D lumen, and the
ine frame rate (12.5 frames/s) (14). Zero pressure condi-
ions were imposed at the outlet and the no-slip condition
as applied at the wall. The detailed characteristics of the
ntracoronary flow field were obtained (Fig. 1D), and
aseline SS at the stent surface (Fig. 1E) was computed as
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1183he product of the gradient of blood velocity at the arterial
all and viscosity.
ata analysis. The analysis was performed only for the
tented arterial segments. Area and volume measurements
ere derived from the 3D reconstructed models; volume
easurements derived from 3D models are more accurate
han IVUS-based ones, which involve linear stacking of
VUS images and neglect curvature effects (15). Neointimal
hickness at follow-up was calculated as the distance be-
ween the stent (baseline) and the lumen (follow-up) recon-
tructed surfaces in 3D space using an in-house developed
lgorithm implemented in Visual Fortran (Compaq Com-
uter Corporation, Houston, Texas). Positive NT values
orresponded to areas of neointimal hyperplasia, whereas
egative NT denoted that the lumen border was outside the
econstructed stent surface and thus, tissue regression with
umen enlargement was present (Fig. 1F and Online Fig.
S). Neointimal thickness was determined along the axial
irection per 0.5 mm and around the vessel circumference
er 10° (at 36 locations) for each cross section; SS was
omputed at the same locations. Cross sections correspond-
Figure 1. 3D Artery and Stent Reconstruction and Distribution of Compute
(Top) Angiogram (A) of a right coronary artery with a stented segment (white
timal hyperplasia (NH) and tissue regression (TR), and 3-dimensional (3D) recon
stented segment. (Bottom) Color-coded velocity proﬁles (D) in 3 in-stent cross
bution at the stent surface and (F) the corresponding neointimal thickness (NT
skewed toward the wall and thus, causes high SS corresponds to 0 NT, whereang to in-stent side branches (identified by IVUS) and their sdjacent segments with a length equal to the diameter of the
ide branch, as well as a part (2.5 mm in length) of the
egment at the entrance and exit of the stent, were excluded
rom the analysis to minimize their influence on the flow
eld and SS computations.
tatistics. Categorical variables were compared between
roups using the chi-square test or Fisher exact test. The
npaired t test or 1-way analysis of variance were used for
omparing continuous variables (presented as the mean 
D) between 2 or 3 groups, respectively. The correlation
etween NT at follow-up and baseline SS at the stent
urface for each patient was investigated using linear regres-
ion analysis. A linear mixed-effects model (random inter-
ept and slope) controlling for patient-to-patient variation
as used to estimate the overall NT-SS relationship in the
atient groups and the influence of drug (sirolimus and
aclitaxel) elution on this relationship (using BMS as the
eference group). The parameters entered in this model
ere SS, stent type, and the interaction between stent type
nd SS (stent type  SS). An adjusted (Bonferroni correc-
ion) alpha level of 0.025 (0.05  2) was used to determine
t the Stent Surface and NT
), in-stent intravascular ultrasound images (B) demonstrating areas of neoin-
tion (C) of the arterial lumen (red) and stent (gray) with detailed view of the
ons and 3D color-coded maps demonstrating (E) the shear stress (SS) distri-
ifferent view (G) is also provided; an area (white circles) where blood ﬂow is
rea with low SS corresponds to increased NT (gray circles).d SS a
lines
struc
secti
). A dtatistical significance for the 2 contrasts (SES  SS vs.
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1184MS  SS and PES  SS vs. BMS  SS) testing the
nteraction, whereas the conventional alpha level of 0.05 was
sed for all other analyses; all tests were 2-tailed. The SPSS
tatistical software package (version 16.0 for Windows,
PSS, Inc., Chicago, Illinois) was used for the analysis.
esults
he baseline clinical and procedural characteristics of the
ES, PES, and BMS patient groups are presented in Table 1.
xcept for a difference regarding patient sex between SES
nd BMS patients, the groups had similar characteristics.
eointimal thickness in SES, PES, and BMS. Quantitative
easurements in the 3D models (Table 2) demonstrated
ignificantly lower neointimal hyperplasia and higher tissue
egression in the DES compared with the BMS group. The
ES group, compared with the PES group, demonstrated
ven lower neointimal hyperplasia and higher tissue regres-
ion burden. Furthermore, mean NT was significantly lower
n DES patients than in BMS patients (0.03 0.07 mm vs.
.16  0.08 mm, p  0.001). The difference in mean NT
etween SES (0.007  0.04 mm) and PES (0.054  0.08
m) patients did not reach statistical significance (p 
.123), but the average of maximum NT was significantly
ower in SES (0.33  0.13 mm vs. 0.46  0.13 mm, p 
.025). Low NT in DES also reflected the more frequently
bserved tissue regression (negative NT) in this group (44%
f all measured in-stent locations, minimum NT: 1.09
m; 49% for SES and 38% for PES) compared with the
Table 1. Baseline Clinical and Procedural Characteristics of the Patient Gr
Characteristics
DES (n 
SES (n  10) PES (n
Age, yrs 58.2 9.5 62.1
Male 70% 100
Cardiovascular risk factors
Diabetes 60% 20
Hypertension 70% 60
Hypercholesterolemia 90% 90
Smoking 30% 20
Clinical presentation
Stable/unstable angina 20%/80% 30%/
Vessels treated
Left anterior descending 40% 30
Left circumﬂex 10% 40
Right coronary artery 50% 30
Balloon pre-dilation 40% 20
Stent length, mm 16.8 4.8 17.2
Stent diameter, mm 2.88 0.21 2.73
Post-procedural coronary blood ﬂow, ml/s 0.84 0.23 0.88
Values are mean SD or %. *Two-group comparison: DES versus BMS. †Three-group comparison:BMS bare-metal stent(s); DES drug-eluting stent(s); PES paclitaxel-eluting stent(s); SES sirolimuMS control group (11% of all measured in-stent locations;
inimum NT: 0.15 mm).
elationship of NT at follow-up with baseline SS at the stent
urface. Average baseline SS at the stent surface was similar
etween DES and BMS (2.02  0.81 Pa vs. 1.74  0.49 Pa,
espectively, p 0.33); the respective averages of minimum SS
0.51 0.49 Pa vs. 0.45  0.37 Pa, p  0.75) and maximum
S (4.67  2.04 Pa vs. 4.27  2.19 Pa, p  0.63) were also
imilar. Furthermore, there was no significant difference be-
ween SES and PES in average SS (1.98 0.58 Pa vs. 2.05
.01 Pa, respectively, p  0.85) and the averages of minimum
S (0.61  0.57 Pa vs. 0.41  0.43 Pa, p  0.37) and
aximum SS (4.17  1.38 Pa vs. 5.17  2.51 Pa, p  0.29).
Linear regression analysis for each patient in the DES group
Figs. 2A and 2C) demonstrated a significant negative corre-
ation of NT at follow-up to baseline in-stent SS in 12 patients
range of the correlation coefficient [r]: 0.67 to 0.07, p 
.02). The respective relationship in the BMS group was
ignificant in 8 patients (r range: 0.61 to 0.11, p  0.001)
Figs. 2B and 2D). Group analysis (Table 3) resulted in a
ignificant inverse correlation between NT and SS in both
ES (slope: 0.03 mm/Pa, p  0.004) and BMS patients
slope:0.05 mm/Pa, p 0.001). After pooling all data from
oth DES and BMS patients, DES were significantly associ-
ted with lower NT (DES vs. BMS: 0.17 mm, p  0.003)
nd baseline in-stent SS was a significant predictor of NT at
ollow-up (slope: 0.05 mm/Pa, p  0.001), whereas the
elationship of NT to SS was not found to be significantly
ifferent between DES and BMS (Table 3).
BMS (n  10) p Value* p Value†) p Value
0.362 64.2 10.2 0.286 0.382
0.211 100% 0.532 0.036
0.170 60% 0.442 0.117
1.00 70% 1.00 0.861
1.00 70% 0.300 0.383
1.00 40% 0.431 0.621
1.00 30%/70% 1.00 0.843
0.295 0.388 0.308
60%
10%
30%
0.628 50% 0.425 0.366
0.852 19.2 5.9 0.270 0.542
0.109 2.95 0.26 0.100 0.090
0.711 0.93 0.28 0.441 0.703
sus PES versus BMS.oups
20)
 10
9.2
%
%
%
%
%
70%
%
%
%
%
4.6
0.18
0.23
SES vers-eluting stent(s).
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1185Linear regression analysis for each patient also revealed
ifferences between the SES and PES group (Figs. 2A
nd 2C). For only 3 of 10 SES patients, a significant
egative correlation of NT to SS was found (r range: 0.31
o 0.15, p  0.001), whereas 9 PES patients showed a
ignificant negative correlation (r range: 0.67 to 0.07;
 0.02). Subgroup analysis (Table 3) demonstrated a
ignificant correlation of NT to SS only in the PES group
slope: 0.05 mm/Pa, p  0.016).
Overall group analysis (Table 3) for prediction of NT at
ollow-up, including 3 groups and using BMS as the
eference group, demonstrated an independent and signifi-
ant effect of sirolimus elution on the relationship of NT at
ollow-up with baseline in-stent SS (interaction coefficient
or SES vs. BMS: 0.04 mm/Pa, p  0.023). Paclitaxel
lution, when compared with BMS, was not found to
ignificantly alter the relationship between NT and SS.
iscussion
he present study explores the effect of baseline in-stent SS
n NT following DES or BMS implantation in humans by
se of realistic 3D coronary artery reconstruction and blood
ow computational analysis. The main findings of this study
re: 1) baseline SS at the stent surface is a significant
redictor of NT at follow-up (inverse correlation) in PES
nd BMS; and 2) sirolimus elution significantly attenuates
he effect of SS on NT, whereas the SS effect remains
Table 2. In-Stent Quantitative Measurements in 3D Reconstructions
Parameter
DES (n  20)
SES (n  10) PES (n  10)
Mean NT, mm‡ 0.007 0.04 0.054 0.08
Max NT, mm 0.33 0.13 0.46 0.13
Min NT, mm 0.34 0.30 0.39 0.36
Mean stent area, mm2 5.93 0.97 5.43 1.22
Mean lumen area, mm2 5.93 1.20 5.03 1.37
Mean NH area, mm2 0.24 0.30 0.52 0.42
Mean NH area burden, %§ 4.27 6.23 9.75 7.99
Max NH area burden, %§ 15.74 13.02 26.18 15.7
Mean TR area, mm2 0.24 0.18 0.11 0.13
Mean TR area burden, %§ 3.81 2.59 2.15 2.55
Max TR area burden, %§ 23.01 19.55 15.18 18.77
Stent volume, mm3 91.62 40.58 95.86 46.38
Lumen volume, mm3 92.25 43.01 89.66 47.67
NH volume, mm3 3.45 3.99 7.99 6.30
NH volume burden, % 4.35 6.36 10.16 8.51
TR volume, mm3 4.08 3.81 1.80 2.25
TR volume burden, % 3.87 2.55 1.92 2.25
*Two-group comparison: DES versus BMS. †Three-group comparison: SES versus PES versus BMS. ‡
§NH area burden NH area/stent area and TR area burden TR area/stent area. NH volume burd
NH neointimal hyperplasia (positive NT); NT neointimal thickness; TR tissue regression (nenchanged under paclitaxel elution. This is the first study Phat investigates the impact of in-stent SS on neointimal
esponse following stent implantation in both SES and PES
ompared with BMS based on the largest up-to-date patient
eries.
T: drug elution and the effect of SS. In-stent neointimal
yperplasia depends on complex mechanisms within the
rterial wall involving mainly SMC, matrix formation, and
ndothelial cells. The interplay of growth factors released
uring vessel injury controls SMC migration and prolifer-
tion through intracellular positive (cyclin-dependent ki-
ases) and negative (cyclin kinase inhibitors) regulators of
ell cycle events (16). Smooth muscle cells migrating from
he media leave their quiescent state and undergo pheno-
ypic modulation switching from a contractile to a synthetic
henotype. Low SS, known to induce phenotypic changes
n endothelial cells and create a proatherogenic environment
17), can also modulate SMC proliferation and migration
ither via endothelial cells or directly in cases of a damaged
ndothelium, such as those immediately after stenting (18),
nd thus, may amplify the neointimal response to vessel
njury.
NT following BMS implantation in humans has been
eported to be inversely correlated to SS (12,19), indicating
n vivo that there is a higher probability for neointimal
yperplasia to occur and be more profound in low SS
egions (13). Although, in our population, average SS after
tenting was within the physiologic range (approximately 2
BMS (n  10) p Value* p Value†p Value
0.123 0.164 0.08 0.001 0.001
0.025 0.59 0.21 0.005 0.004
0.736 0.08 0.05 0.008 0.029
0.327 6.46 1.33 0.100 0.172
0.133 5.17 1.62 0.583 0.317
0.113 1.33 0.56 0.001 0.001
0.104 21.85 10.36 0.001 0.001
0.123 45.08 21.11 0.001 0.002
0.073 0.04 0.07 0.005 0.009
0.166 0.62 1.01 0.002 0.011
0.368 7.21 14.06 0.092 0.151
0.830 119.61 37.85 0.115 0.288
0.900 93.19 26.39 0.884 0.979
0.070 27.19 16.4 0.002 0.001
0.101 21.81 10.36 0.001 0.001
0.120 0.77 1.43 0.018 0.030
0.087 0.59 1.02 0.001 0.005
T per patient was calculated as the average of NT in all axial and circumferential in-stent locations.
H volume/stent volume and TR volume burden TR volume/stent volume.
NT); 3D 3-dimensional; other abbreviations as in Table 1.Mean N
en Na), there was heterogeneity in the SS distribution at the
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1186tent surface due to the local geometry, and, thus, low SS
reas were present. An overall significant correlation be-
ween NT at follow-up and baseline in-stent SS was found
p  0.001), and SS was demonstrated as a significant
redictor of NT independently of the lower NT in DES
ompared with BMS. Of note, DES subgroup analysis
howed: 1) the NT-SS relationship was significant only in
ES; and 2) sirolimus elution, but not paclitaxel elution,
ignificantly attenuated the effect of SS on NT compared
ith BMS controls. Two previous studies have investigated
he effect of SS on NT in SES. Gijsen et al. (8) reported that
T 6 months after SES implantation was significantly
elated to SS in 4 of the 6 patients studied, and tissue
egression was attributed to high SS. The other available
tudy investigated the correlation between neointimal hy-
erplasia volume and SS in a diabetic population 9 months
fter SES and found no association between the 2 variables
9). The present study demonstrated a significant inverse
T to SS relation in only 3 of the 10 SES patients with an
Figure 2. Relationship of NT With SS per Patient and Group
Relationship (regression lines) between neointimal thickness at follow-up and
(orange lines  sirolimus-eluting stent[s]; green lines  paclitaxel-eluting ste
provided for a representative (with a slope close to the corresponding group’s
(D) bare-metal stent(s). Abbreviations as in Figure 1.verall nonsignificant correlation in the SES group, whereas ihis correlation was significant in 9 of the 10 PES patients.
lthough some differences in data analysis do not allow
irect comparison of this study to the previous ones, it
eems that the role of SS after SES implantation is limited
ue to an attenuation of the SS effect by sirolimus elution,
s supported by our results.
The aforementioned differences in the effect of sirolimus
ersus paclitaxel elution on the NT-SS relationship reflect
he distinct cellular mechanisms of action of the 2 drugs and
he association of these mechanisms with the SS signaling
ascades. Sirolimus binds to its cellular target (mammalian
arget of rapamycin) leading to a decrease of the positive
blocks the p70S6 kinase pathway of the cyclin-dependent
inases) and an increase of the negative (cyclin kinase
nhibitors p27 and p21) regulators of the cell cycle (20); the
nal effect is the arrest of the cell cycle at the G0 phase
nhibiting cell migration and proliferation. The sirolimus-
ensitive p70S6 kinase pathway has also been reported to be
major signaling pathway through which low SS mediates
e in-stent shear stress for each patient in (A) the drug-eluting stent group
and (B) the bare-metal stent group. All data points (scatter plots) are also
ge slope) patient case in (C) sirolimus- and paclitaxel-eluting stent(s), andbaselin
nt[s])
averats effects of cell cycle up-regulation (21), deoxyribonucleic
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1187cid synthesis and consequently, intimal growth. Further,
igh SS has been reported to induce cell cycle and growth
rrest by up-regulating cyclin kinase inhibitor p21 (22,23).
aclitaxel is a nonspecific microtubule-stabilizing agent
esulting in reduced cell division and mobility (16). How-
ver, paclitaxel-induced stabilization of the cytoskeleton has
een found to sensitize endothelial cells for SS effects (24).
n addition, sirolimus and paclitaxel have a dissimilar impact
n SMC phenotype in vitro; SMC under sirolimus treat-
ent adopt a differentiated contractile phenotype, whereas
aclitaxel treatment induces a dedifferentiated synthetic
henotype (25). Different SMC phenotypes have also been
bserved in a recent histopathological investigation of in-
tent restenotic tissues according to stent type in humans. A
ynthetic phenotype was more frequent in both PES and
MS, whereas a contractile-intermediate phenotype was
ainly found in SES (26). Low SS has also been reported to
romote SMC and endothelial cell dedifferentiation (27).
eointimal growth in SES versus PES. Localized delivery of
mmunosuppressive and antineoplastic agents (e.g., siroli-
us and paclitaxel, respectively) using DES has consider-
Table 3. Linear Mixed-Effects Modeling Analysis for t
at Follow-Up According to Stent Type Group
Analysis Group Parameter
BMS Intercept, mm
SS, mm/Pa
DES Intercept, mm
SS, mm/Pa
SES Intercept, mm
SS, mm/Pa
PES Intercept, mm
SS, mm/Pa
DES vs. BMS Intercept, mm stent type
DES vs. BMS, mm
SS, mm/Pa
Stent type  SS
DES  SS vs. BMS  SS, mm/Pa
SES, PES vs. BMS Intercept, mm stent type
Stent type  SS
BMS (reference)
SES, mm
PES, mm
SS, mm/Pa
Stent type  SS
BMS  SS (reference)
SES  SS, mm/Pa
PES  SS, mm/Pa
The interaction parameter (stent type  SS) estimates the influence
represents the difference between the slope of the stent group tested a
are derived from the type-III F test for any difference between the 3 gro
SS as the reference group) was assessed at the Bonferroni corrected al
Abbreviations as in Table 1.bly changed the picture in terms of both in-stent neointi- aal growth and clinical benefit for patients undergoing
ercutaneous coronary interventions (28). In our patients,
ean NT following DES implantation was significantly
nd clearly lower compared with BMS reflecting both the
educed neointimal growth and the higher frequency of
issue regression. Differences were also evident between
ES and PES; neointimal hyperplasia burden was lower in
ES according to all area and volume indexes, and the
verage of maximum NT was significantly reduced com-
ared with PES (p  0.025), demonstrating a higher
nhibition of neointimal hyperplasia by SES.
The differential degree of neointimal growth inhibition
y SES versus PES has been recently demonstrated in large
atient registries and randomized trials (29). Neointimal
yperplasia estimated by angiography or IVUS has been
eported to be significantly reduced in SES versus PES
30,31). In terms of clinical benefit, significantly lower rates
f revascularization have been reported after SES, when
ompared with PES, implantation both in the total patient
opulation and in high-risk groups (e.g., diabetics) (32,33).
urthermore, DES type (PES vs. SES) has been found to be
le of Baseline In-Stent SS in Predicting NT
egression Coefficient 95% CI p Value
0.26 0.17 to 0.35 0.001
0.05 0.08 to0.03 0.001
0.09 0.02 to 0.15 0.011
0.03 0.05 to0.01 0.004
0.03 0.02 to 0.08 0.206
0.01 0.03 to 0.01 0.079
0.14 0.02 to 0.26 0.026
0.05 0.08 to0.01 0.016
0.26 0.17 to 0.34 0.001
0.17 0.28 to0.06 0.003
0.05 0.08 to0.03 0.001
0.02 0.01 to 0.05 0.148
0.26 0.17 to 0.34 0.001
0.002*
—
0.23 0.34 to0.11 0.001
0.12 0.23 to 0.01 0.054
0.05 0.08 to0.03 0.001
0.048*
—
0.04 0.01 to 0.07 0.023†
0.01 0.03 to 0.04 0.710†
g elution (stent type) on the NT-SS relationship, and its coefficient
slope of the BMS control group. *The p values for 3-group comparison
S vs. PES vs. BMS). †Significance for these 2 contrasts (using BMS
el of 0.025 (0.05 2).he Ro
R
of dru
nd the
ups (SE
pha levmong the predictive factors of restenosis (34). These
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1188ifferences in clinical studies may be explained in part by the
forementioned distinct biological properties of the eluted
rugs and their association with the SS effect on the
eointimal response.
Despite the potent antiproliferative effect of DES, neo-
ntimal hyperplasia or even in-stent restenosis may still
ccur especially when DES are used in complex clinical and
natomic settings (35). Lesions in arterial locations with an
dverse hemodynamic environment of disturbed flow and
ow SS (e.g., bifurcations and highly curved segments) are at
igh risk of restenosis after stenting. Although both SES
nd PES, when compared with BMS, primarily reduce
eointimal growth, sirolimus presumably exerts an addi-
ional, second-order, favorable action by abrogating the low
S effect, which could potentially amplify the neointimal
esponse in certain regions. Therefore, the treatment of
esions located in areas with a pro-restenotic hemodynamic
ilieu could possibly justify the selection of a particular
ES type by interventionists for reducing neointimal hy-
erplasia and improving clinical outcomes. However, large
atient studies are needed to confirm our findings and
ddress the efficacy of this strategy.
tudy limitations. The number of patients is rather small in
ach patient group, even if it is the largest to date for such
n investigation. The large number of in-stent locations (on
verage 792 locations per stented segment) axially and
ircumferentially, where NT and SS were calculated and
nterrelated, also strengthens the validity of our results.
For the 3D stent reconstructions, only follow-up data
ere used; this approach increases the accuracy of calculat-
ng the difference between the lumen and stent surface in
D space (i.e., NT), but does not account for any changes in
D stent geometry over the follow-up period and any
uboptimal stent expansion, which may have caused incom-
lete stent apposition at baseline. However, stent changes
ver a 6-month follow-up period have been reported to be
inor (12), and these limitations are not likely to have
ignificantly influenced our results.
Furthermore, the assumptions (Newtonian viscosity and
igid arterial walls) in the blood flow simulation are ac-
nowledged, but are not considered to have a significant
mpact on our results, because stented regions are quite rigid
nd the relative SS distribution is more important rather
han its absolute value.
onclusions
he use of 3D coronary artery reconstruction coupled with
omputational fluid dynamics for calculating in-stent base-
ine SS and NT 6 months after DES (SES and PES) and
MS implantation in 30 patients demonstrated an overall
nverse correlation of NT to SS. Both DES and SS were
ound to be independent predictors of NT. Compared with
MS, the relationship between NT and SS is significantly
1educed by sirolimus elution but remains unchanged under
aclitaxel elution. Common pathways through which both
irolimus and SS modulate cell migration and proliferation
xplain why sirolimus abrogates the SS effect, whereas the
athobiology of neointimal formation after PES implanta-
ion resembles more that of BMS and responds similarly to
S. These differences between the 2 DES types may account
or the higher degree of neointimal growth inhibition by
ES compared with PES observed in large patient trials.
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APPENDIX
or more information about the method for 3D coronary artery reconstruction,
lease see the online version of this article.
